We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Defibrillators Offer Benefits for Cardiomyopathy Patients

By HospiMedica International staff writers
Posted on 12 Sep 2017
Print article
Cardiac resynchronization therapy (CRT) patients diagnosed with non-ischemic cardiomyopathy would live longer and have fewer hospital admissions if they also received a defibrillator, claims a new study.

Researchers at Aston University (Birmingham, United Kingdom), the University of Birmingham (UB; United Kingdom), and other institutions conducted a study to determine the benefit of CRT with defibrillation (CRT-D) versus CRT with pacing (CRT-P) for patients with non-ischemic cardiomyopathy (NICM), in order to determine which method was superior for reducing complication in patients with left ventricular midwall fibrosis (MWF).

Clinical events were quantified in patients with NICM with MWF (68 patients) or without MWF (184 patients), who underwent cardiac magnetic resonance imaging (MRI) prior to CRT device implantation. The results revealed that total mortality, total mortality or heart failure hospitalization, and total mortality or hospitalization for major adverse cardiac events were all lower after CRT-D than after CRT-P in patients with MWF, but not in those without MWF. The study was published on August 28, 2017, in Journal of the American College of Cardiology (JACC).

“The addition of a defibrillator would be very advantageous to patients who also have heart muscle scar tissue, in that they will potentially live longer and will be less likely to be admitted to hospital for heart failure or other cardiac problems,” concluded senior author professor of cardiology Francisco Leyva, MD, of Aston University. “We are recommending that defibrillators should be added to patients with cardiomyopathy with heart muscle scars who are being treated with cardiac resynchronization therapy.”

A CRT implanted device coordinates the contractions between the heart’s left and right ventricles, while an implanted defibrillator helps to control life-threatening arrhythmias. In cardiomyopathy, the heart muscle becomes enlarged or thickens, and in some cases muscle tissue is replaced with scar tissue. The heart thus grows weaker and less able to pump blood and maintain normal electrical rhythm. This can lead to heart failure, irregular pulse, and complications that include ascites and valvular problems.

Related Links:
Aston University
University of Birmingham
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Anesthesia Workstation
X40

Print article

Channels

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more